Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $6.8B |
| Sales growthchange from the year before | +14.2% |
| Gross marginshare of sales left after the direct cost of what it sells | 80.5% |
| Operating marginshare of sales left after running the business | 30.7% |
| Net marginshare of sales kept as profit | 27.3% |
| Return on invested capitalprofit made on each $100 put into the business | 73.7% |
| Return on equityprofit vs. shareholders' accounting value | 149.8% |
| Debt / equitydebt vs. shareholders' accounting value | 0.81 |
| Interest coverhow many times profit covers interest payments | 103.7x |
| Change in share countnegative = the company is buying back its shares | -0.9% |
3 insiders sold $26.8M (all under pre-arranged plans) on the open market.
| Ohlgart ChristianeChief Financial Officer | Sold (plan)Aug 4 | 387 shat $164.59 · $64K |
| Xie MichaelVp, Engineering & Cto · Director | Sold (plan)Aug 3 | 3,121 shat $162.63 · $508K |
| Xie KenPresident & Ceo · Director | Sold (plan)Aug 3 | 161,482 shat $162.66 · $26.3M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy